Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour.

Article English OPEN
Weide, Benjamin; Faller, Christine; Elsässer, Margrit; Büttner, Petra; Pflugfelder, Annette; Leiter, Ulrike; Eigentler, Thomas Kurt; Bauer, Jürgen; Meier, Friedegund; Garbe, Claus;
  • Publisher: Public Library of Science (PLoS)
  • Journal: PLoS ONE,volume 8,issue 6 (issn: 1932-6203, eissn: 1932-6203)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC3692543, doi: 10.1371/journal.pone.0066953
  • Subject: Research Article | Diagnostic Medicine | Malignant Skin Neoplasms | Medicine | Health Care Policy | Cancer Risk Factors | Skin Neoplasms | Oncology | Q | Melanomas | R | Dermatology | Malignant Melanoma | Health Risk Analysis | Science | Cancer Detection and Diagnosis | Skin Tumors | Cancers and Neoplasms | Non-Clinical Medicine

BACKGROUND: A direct comparison of prognosis between patients with regional lymph node metastases (LNM) detected synchronously with the primary melanoma (primary LNM), patients who developed their first LNM subsequently (secondary LNM) and those with initial LNM in mela... View more
Share - Bookmark